These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2695128)

  • 21. Recent pharmacologic advances in antidepressant therapy for the elderly.
    Preskorn SH
    Am J Med; 1993 May; 94(5A):2S-12S. PubMed ID: 8503477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
    López-Muñoz F; Alamo C; Juckel G; Assion HJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120
    [No Abstract]   [Full Text] [Related]  

  • 24. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL; Sunderland T; Cohen RM
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moclobemide for depression.
    Drug Ther Bull; 1994 Jan; 32(1):6-8. PubMed ID: 7635005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MAO inhibitors and depressive disorders today].
    Bonamy D; Olié JP; Lôo H
    Encephale; 1983; 9(2):123-36. PubMed ID: 6641614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review.
    Oxenkrug GF
    Neurobiology (Bp); 1999; 7(2):213-24. PubMed ID: 10591054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current views of the mechanism of action of antidepressants].
    Zieba A; Pawłowski L
    Psychiatr Pol; 1993; 27(3):317-24. PubMed ID: 8356178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E; Chodera A
    Pol Merkur Lekarski; 1997 Jul; 3(13):1-4. PubMed ID: 9432289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL; Ascher JA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interactions with reversible monoamine oxidase-A inhibitors.
    Callingham BA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S42-50. PubMed ID: 8313396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders.
    Liebowitz MR; Hollander E; Schneier F; Campeas R; Welkowitz L; Hatterer J; Fallon B
    Acta Psychiatr Scand Suppl; 1990; 360():29-34. PubMed ID: 2248064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.